AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05698368 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindset intervention
Description: Participants receive a digital mindset intervention to improve mindsets about osteoarthritis and exercise.
Study NCT05698368 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active comparator
Description: Participants receive a series of osteoarthritis education videos and reflective questions that matches the digital mindset intervention in duration and attention.
Study NCT05481307 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RLD2202
Description: Take it once a day per period
Study NCT05481307 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RLD2203
Description: Take it once a day per period
Study NCT05865197 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Data collection of clinically relevant signals using home-based sensor system
Study NCT05463861 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lemborexant
Description: Lemborexant tablet administered orally once daily.
Study NCT05463861 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to match Lemborexant tablet administered orally once daily.
Study NCT06090656 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab combined with Sintilimab
Description: Bevacizumab combined with sintilimab, sindilizumab 200 mg IV d1, Q3W, combined with bevacizumab 15 mg/kg IV d1, Q3W treatment, treatment continued until disease progression, development of intolerable toxic reactions
Study NCT06090656 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Transcatheter arterial chemoembolization
Description: Transcatheter arterial chemoembolization, patients were treated with cTACE, and the efficacy was assessed by repeat CT/MRI 1 month after the initial treatment, and if the tumor still had arterial phase enhancement, TACE treatment could be supplemented until treatment failure and withdrawal of consent.
Study NCT05743920 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-help Forest Bathing
Description: The self-help forest bathing includes two sessions (i.e., participants will perform the first intervention within week 1 to 3, and the second intervention within week 4 to 6) that are related to the following forest bathing activities : (a) forest meditation, (b) forest walking, (c) calling attention to sensory experiences of the forest, including seeing, hearing, touching, and smelling, and (d) building connection to the nature by partnership invitation. Each session will last for 45 minutes.
Study NCT05743920 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Self-help Forest Bathing
Description: The self-help forest bathing includes two sessions (i.e., participants will perform the first intervention within week 1 to 3, and the second intervention within week 4 to 6) that are related to the following forest bathing activities : (a) forest meditation, (b) forest walking, (c) calling attention to sensory experiences of the forest, including seeing, hearing, touching, and smelling, and (d) building connection to the nature by partnership invitation. Each session will last for 45 minutes.
Study NCT06132035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CG-P5 peptide
Description: Patient will instill daily 1 package of CG-P5 peptide eye drops in the study eye \[self-administered\] using the single use tear-off disposable packaging
Study NCT06132035 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patient will instill daily 1 package of Placebo eye drops in the study eye \[self-administered\] using the single use tear-off disposable packaging
Study NCT06132035 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aflibercept Injection [Eylea]
Description: Patient will receiver Eylea® (Aflibercept) intravitreal injection once in a month
Study NCT05551533 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kampung Care App
Description: Please refer to the previous session
Study NCT05416190 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Lupus anticoagulant testing
Description: The patient will have a visit during which a blood sample will be taken, a clinical examination will be performed, and data will be collected.
Study NCT05821699 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Patients will receive the current standard-of-care for pain management in the aftermath of surgery: a standardized prescription protocol, hospital-system approved discharge instructions which provide written instruction on how to taper opioid use, links to written/online resources for opioid misuse, overdose prevention, and State-approved disposal options.
Study NCT04678583 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resection of colorectal liver metastases
Description: Comparison of two liver surgery methods
Study NCT04678583 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Resection of colorectal liver metastases
Description: Comparison of two liver surgery methods
Study NCT06181526 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aleeto
Description: According to the groups, patients would be treated with Aleeto via intrathecal injection or intravenous injection, and the specific dosage and administration method of Aleeto will depend on the grouping.
Study NCT06181526 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: intravenous injection
Description: According to the groups, patients would be treated with Aleeto or placebo +100ml sodium chloride injection via intravenous injection, depend on the grouping
Study NCT06181526 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: intrathecal injection
Description: According to the groups, patients would be treated with Aleeto or placebo + 8ml sodium chloride injection via intrathecal injection, depend on the grouping.
Study NCT05298488 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home office
Description: Working from home
Study NCT05298488 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home office
Description: Working from home
Study NCT05298488 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Office
Description: Working at the office
Study NCT05298488 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Office
Description: Working at the office
Study NCT05219357 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Ayu-Care
Description: Ayurveda treatment modalities includes three parts to manage mental health Satwawajay Chikitsa, Yuktivyapashray and Daivyapashray Chikitsa. It is based on personalised whole person approach.
Study NCT05219357 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Usual-Care
Description: Management strategies includes restraints, emergency medications, behavioral interventions, with a special focus on the pharmacological interventions.
Study NCT05625984 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fascigel
Description: The product is a Class III Medical Device. Structure is made by 1% sodium hyaluronate polysaccharide in normal saline solution.
Study NCT04931264 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: YuWell YE660D Electronic Sphygmomanometer
Description: Measurement blood pressure by YuWell YE660D Electronic Sphygmomanometer and Desk Mercury Sphygmomanometer
Study NCT06012682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin Hydrochloride
Description: The investigational medicinal product/placebo will be dispensed to study participants by study staff during randomization visits V1, V2, V3, V4, V5 and V6.~The randomized patient will receive the investigational medicinal product/placebo in tablets of 500 mg. The received tablets will be dispensed in an amount sufficient for the next visit. Patients will be asked to bring unused medicine and all empty ones packaging to the Center for each subsequent visit. The investigational medicinal product/placebo will be administered orally 500 mg three times a day (Table No. 1). The dose of the study product will be gradually increased from 500 mg/day to 1500 mg/day in order to avoid or reduce side effects related to taking the study medicinal product metformin
Study NCT06012682 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The investigational medicinal product/placebo will be dispensed to study participants by study staff during randomization visits V1, V2, V3, V4, V5 and V6.~The randomized patient will receive the investigational medicinal product/placebo in tablets of 500 mg. The received tablets will be dispensed in an amount sufficient for the next visit. Patients will be asked to bring unused medicine and all empty ones packaging to the Center for each subsequent visit. The investigational medicinal product/placebo will be administered orally 500 mg three times a day (Table No. 1). The dose of the study product will be gradually increased from 500 mg/day to 1500 mg/day in order to avoid or reduce side effects related to taking the study medicinal product metformin
Study NCT04776317 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ChAdV68-S
Description: Chimpanzee Adenovirus serotype 68 - Spike (ChAdV68-S) is a replication-defective, E1, E3 E4Orf2-4 deleted adenoviral vector based on chimpanzee adenovirus 68 (C68, 68/SAdV-25, originally designated as Pan 9), which belongs to the sub-group E adenovirus family. A single 0.5 mL intramuscular injection will be administered in the deltoid muscle. When possible, the prime vaccine and boost vaccine should be administered in different arms.
Study NCT04776317 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ChAdV68-S-TCE
Description: Chimpanzee Adenovirus 68 - Spike plus additional SARS-CoV-2 T cell epitopes (ChAdV68-S-TCE) is a replication-defective, E1, E3 E4Orf2-4 deleted adenoviral vector based on chimpanzee adenovirus 68 (C68, 68/SAdV-25, originally designated as Pan 9), which belongs to the sub-group E adenovirus family. A single 0.5- or 1.0-mL (depending on dose level) intramuscular injection will be administered in the deltoid muscle. When possible, the prime vaccine and boost vaccine should be administered in different arms.
Study NCT04776317 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SAM-LNP-S
Description: Self-Amplifying mRNA - Lipid Nanoparticles - Spike (SAM-LNP-S) is a SAM vector based on Venezuelan Equine Encephalitis Virus (VEEV). A single 0.25 mL or 0.5 mL (depending on dose level) intramuscular injection will be administered in the deltoid muscle. When possible, the prime vaccine and boost vaccine should be administered in different arms.
Study NCT04776317 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SAM-LNP-S-TCE
Description: Self-Amplifying mRNA - Lipid Nanoparticles -Spike plus additional SARS-CoV-2 T cell epitopes (SAM-S-TCE) is a SAM vector based on Venezuelan Equine Encephalitis Virus (VEEV). A single 0.25 or 0.5 mL (depending on dose level) intramuscular injection will be administered in the deltoid muscle. When possible, the prime vaccine and boost vaccine should be administered in different arms.
Study NCT04776317 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sodium Chloride, 0.9%
Description: The diluent used for this study will be 0.9% Sodium Chloride Injection, USP, and is a sterile, nonpyrogenic, isotonic solution of sodium chloride and water for injection. Each milliliter (mL) contains sodium chloride 9 mg. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. 0.308 mOsmol/mL (calc.). 0.9% Sodium Chloride Injection, USP contains no preservatives.
Study NCT03947190 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: R21/Matrix-M
Description: R21: Protein particle malaria vaccine candidate in Matrix-M: Saponin based vaccine adjuvant.
Study NCT03947190 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ChAd63/MVA ME-TRAP
Description: ChAd63, chimpanzee adenovirus serotype 63; ME-TRAP, multiple epitope string fused to the thrombospondin-related adhesion protein; MVA, modified vaccinia Ankara.
Study NCT03947190 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: intradermal injection (ID) or direct venous injection (DVI) of PfSPZ Challenge
Description: PfSPZ Challenge: cryopreserved Plasmodium falciparum sporozoites.
Study NCT05306626 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Building Emotion Awareness and Mental Health (BEAM)
Description: The BEAM Program is based on best-practices in telehealth and science-based program design principles aimed at promoting maternal mental health and supportive parenting. The BEAM Program mobile application is designed and managed by Tactica Interactive and hosted on the University of Manitoba secure servers. The weekly group telehealth sessions will be led by clinical coaches (a mental health professional or trainee) and will use the secure videoconferencing platform Zoom (Healthcare license). Parent coaches will be mothers who have recently participated in another research group-based mental health intervention. Parent coaches will engage with participants on the community peer support forum and attend weekly telehealth sessions. The therapeutic aims of the BEAM program are to improve anxiety and depression symptoms and parenting skills using content that draws from the Unified Protocol, and emphasizes self-compassion, effective communication practices, and social support networks.
Study NCT04894721 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin
Description: 0,6mg/kg of weight orally on days 1 and 7
Study NCT04894721 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A substance with similar physical characteristics as ivermectin, without the active drug ingredient
Study NCT05208502 — intervention group
Intervention type: DEVICE
Intervention: DSA monitor
Description: Next Generation SedLine features an enhanced signal processing engine, which provides processed EEG parameters. This four channel EEG monitor for the monitoring of perioperative anesthesia depth prevent overdose of medication and may help for individualized anesthetic plan
Study NCT05135871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mavacamten
Description: Single fasted oral dose of Mavacamten 15/25 mg on Day 1
Study NCT05569902 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active tACS
Description: transcranial alternating current stimulation is a non-invasive method of entraining specific frequency bands in the brain by applying weak intensities of electric current in a desired shape and phase to the desired brain regions.
Study NCT05569902 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham tACS
Description: transcranial alternating current stimulation is a non-invasive method of entraining specific frequency bands in the brain by applying weak intensities of electric current in a desired shape and phase to the desired brain regions.
Study NCT04905550 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Almonertinib
Description: Almonertinib 110mg p.o qd. Treatment with Almonertinib will continue until progression or unacceptable toxicity.
Study NCT04905550 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Radiotherapy(SRT) or Stereotactic Radiosurgery(SRS) or Whole-Brain Radiotherapy(WBRT)
Description: Image guided, 24-15 Gy\*1F was recommended if use SRS. 9-12 Gy\*3F/1W or 6Gy×5F/1W was recommended if use SRT. 30Gy/10F/2W for WBRT, large residual lesions will be treated with a local dose (≤DT 45Gy/15F).
Study NCT06435208 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Subgingival instrumentation
Description: All the participants will undergo scaling and root planning with hand scalers, curettes and ultrasonic scaler.
Study NCT06021925 — intervention group
Intervention type: OTHER
Intervention: Obstetrical history
Description: Selection of donors by EFS retrospectively on the basis of inclusion criteria. Information note sent by e-mail, non-opposition as well as a questionnaire to be completed online to obtain data on obstetrical history.
Study NCT06021925 — intervention group
Intervention type: OTHER
Intervention: Anti-HLA Antibody tests
Description: Analyze responses in relation to the results of the anti-HLA Antibody tests performed at the time of donation.
Study NCT06235866 — intervention group
Intervention type: OTHER
Intervention: Pulmonary rehabilitation
Description: According to the pulmonary rehabilitation guidelines, patients with severe COVID-19 were given regular rehabilitation treatment, including breathing exercises and physical rehabilitation exercises.
Study NCT05709860 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: EMC2 PrEP Educational Tool
Description: Patients will receive an interactive PrEP Educational Tool. This interactive tool will be securely sent via the patient portal. After logging into their portal, patients will have the opportunity to review the information on their own time.
Study NCT05709860 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Discrete Scheduling of a Dedicated PrEP Visit
Description: Within the interactive PrEP Educational Tool, patients who choose to will have the opportunity to discretely schedule a dedicated PrEP visit with a primary care clinician trained on PrEP delivery. The clinician will have time reserved to allow for 'rapid' scheduling.
Study NCT05983419 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ESD
Description: Complete resection of Barrett's esophagus harboring neoplasia with endoscopic submucosal dissection.
Study NCT04992572 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol Injection
Description: 25mg Propofol administered by injection
Study NCT04992572 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine Hydrochloride, Injectable
Description: Licocaine administered locally via injection.
Study NCT05904561 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: low level laser therapy
Description: comparing between the effect of low level laser therapy (LLLT) and pulsed ultrasound on post-partum carpal tunnel syndrome. All interventions that were pre-specified to be administered as part of the protocol, even if a particular intervention is not of interest
Study NCT05904561 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: low level laser therapy
Description: comparing between the effect of low level laser therapy (LLLT) and pulsed ultrasound on post-partum carpal tunnel syndrome. All interventions that were pre-specified to be administered as part of the protocol, even if a particular intervention is not of interest
Study NCT05619029 — intervention group
Intervention type: RADIATION
Intervention: X-ray
Description: Chest radiographs
Study NCT05644314 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The drug-eluting stent
Description: Vertebral artery drug-eluting stents Maurora® was approved for marketing in 2020 and has been shown to be effective in reducing restenosis in clinical trials.
Study NCT06327698 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab
Description: Injectable solution
Study NCT06327698 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anlotinib
Description: capsule
Study NCT04921566 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Torasemide tablet 10 mg
Description: Torasemide is manufactured by Pharmtechnology LLC, Belarus. Each tablet contains 10 mg of torasemide.
Study NCT04921566 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Toradiur® tablet 10 mg
Description: Toradiur® is manufactured by MEDA Manufacturing Cologne, Germany. Each tablet contains 10 mg of torasemide.
Study NCT05532865 — intervention group
Intervention type: OTHER
Intervention: Blood samples
Description: 80 ml of blood samples collected at inclusion and at 18 months
Study NCT05532865 — intervention group
Intervention type: OTHER
Intervention: Stool samples
Description: A stool sample for collection of digestive microbiota at inclusion
Study NCT05532865 — intervention group
Intervention type: OTHER
Intervention: Skin swab samples
Description: A skin swab sample for collection of skin microbiota at inclusion and at 18 months
Study NCT05532865 — intervention group
Intervention type: OTHER
Intervention: Questionnaires on quality of life, pain and disability
Description: At inclusion and each year for 5 years
Study NCT05532865 — intervention group
Intervention type: OTHER
Intervention: Skin biopsies
Description: At inclusion and 18 months
Study NCT05582486 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: obstetric violence prevention education intervention
Description: While the training program for the prevention of obstetric violence consisting of 16 sessions was applied by the researcher to the midwives and nurses in the experimental group, no intervention was applied to the midwives and nurses in the control group.
Study NCT05361369 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule
Description: Fixed dose combination of 600 mg fenticonazole nitrate + 1000 mg tinidazole + 100 mg lidocaine
Study NCT05255146 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Atricure Inc. Nitrous oxide Cryoprobe
Description: Cryoanalgesia will be given by applying a nitrous oxide-cooled probe (AtriCure, Inc. 2000) locally to intercostal nerves in the 4th, 5th, and 6th rib spaces after completion of the surgical repair and before surgical closure. The probe will be cooled to -60°C and held on each location for 60 sec.